subgroup of
drug)
→
CapableOf
→
enter the market
| Typicality: | 0.764 |
| Saliency: | 1.000 |
| within the next 5–10 years | 10 | temporal |
| to treat patients | 8 | purpose |
| in 1985 | 6 | temporal |
| new drug → enter → the market | 46 |
| new drug → hit → the market | 36 |
| new drug → come on → the market | 27 |
| new drug → come to → market | 24 |
| new drug → reach → the market | 17 |
| new drug → come onto → the market | 11 |
| new drug → enter → the marketplace | 4 |
| new drug → come to → the market | 4 |
| new drug → come into → the market | 3 |
| new drug → go on → the market | 3 |
| negative | neutral | positive |
| 0.226 | 0.572 | 0.202 |
| Raw frequency | 175 |
| Normalized frequency | 1.000 |
| Modifier score | 0.767 |
| Perplexity | 110.911 |